WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Dicerna Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-04 11:40 am Purchase |
2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
WELLINGTON MANAGEMENT CO LLP | 4,317,623 5.750% |
3,648,932 (+545.68%) |
Filing |